Physician

Robert Allan Lizer, D.O.

According to 2025 Medicare claims, Robert Lizer, D.O. (NPI: 1184624280) practices addiction medicine in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is METHODIST MEDICAL CENTER OF ILLINOIS (NPI: 1184670663; TIN: 370661223) and primary practice location at 61614-5021. Lizer is affiliated with the Esse Health ACO, LLC (ACO ID: D0140), participating under the REACH model.

Lizer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 1,017 HCPCS/CPT codes, and received $82,259 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,676 prescription claims across 567 beneficiaries totaling $653,468 in drug costs, led by Ozempic (Semaglutide). DME data shows 183 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $98,531 to $82,259. In contrast, Part D prescription costs have risen steadily, from $345,352 to $653,468. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $17,944 and ending at $10,585.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	449	1,707	$98,531
2016	540	2,124	$118,576
2017	646	2,820	$176,580
2018	590	2,488	$165,547
2019	400	1,907	$114,166
2020	309	1,300	$82,985
2021	311	1,339	$98,358
2022	286	1,289	$99,480
2023	274	1,085	$84,011
2024	258	1,017	$82,259

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	506	7,338	$345,352
2016	510	7,583	$397,927
2017	545	8,282	$436,468
2018	686	9,104	$507,069
2019	528	7,859	$505,691
2020	474	7,491	$469,828
2021	497	7,253	$509,581
2022	503	7,235	$539,089
2023	500	7,553	$674,999
2024	567	7,676	$653,468

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	280	$14,967
2016	36	373	$10,401
2017	36	234	$3,874
2018	51	357	$7,600
2019	56	330	$5,150
2020	25	315	$34,795
2021	23	282	$36,501
2022	22	205	$27,483
2023	22	215	$13,120
2024	15	183	$11,435

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	184	184	$124
90662	Influenza vaccine split virus, preservative free	51	53	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	255	598	$80
G0008	Administration of influenza virus vaccine	50	51	$31
36415	Insertion of needle into vein for collection of blood sample	40	53	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	73	3,490	$116,957
Eliquis	Apixaban	57	3,600	$68,003
Jardiance	Empagliflozin	31	2,713	$52,292
Farxiga	Dapagliflozin Propanediol	38	2,380	$45,851
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	1,620	$35,451

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	16	$2,573
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$2,273
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$2,061
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	22	$1,361
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	14	$728

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Robert Allan Lizer, D.O.?

Tedicare shows public-source Medicare data for Robert Allan Lizer, D.O. (NPI 1184624280), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Allan Lizer, D.O. have ACO affiliation data?

Robert Allan Lizer, D.O. is shown with ACO affiliation data for Esse Health ACO, LLC (REACH, ACO ID D0140).

What billing organization is linked to Robert Allan Lizer, D.O.?

Robert Allan Lizer, D.O. is linked to METHODIST MEDICAL CENTER OF ILLINOIS (billing NPI 1184670663) in the available physician profile data.

Does Robert Allan Lizer, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.